Probably the best quarterly I've seen for painchek. Although I got it wrong with the FDA timelines. Clinical trial hasn't even started yet. Forecast to begin Q4 CY22. Sales in NZ,Scotland,England,Wales and 60% of RACs in Australia. So much to look forward to! $585k receipts from customers for the qtr. The growth continues. Very positive.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-2
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.001(3.45%) |
Mkt cap ! $47.43M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 2.9¢ | 2.8¢ | $27.86K | 995.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 186389 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 688799 | 1 |
View Market Depth
| Last trade - 10.22am 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.8¢ |
Change
-0.001 ( 3.45 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.8¢ | 2.8¢ | 132900 | ||
| Last updated 10.22am 02/05/2024 ? | |||||
| PCK (ASX) Chart |